Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Squamous Cell Carcinoma of Head and Neck × Educational Status × 90 days × Clear all

Sponsor

Conditions

Colorectal Neoplasms 8 Breast Neoplasms 7 Lung Neoplasms 6 Prostatic Neoplasms 4 Obesity-Related Malignant Neoplasm 3 Neoplasm Metastasis 3 Lymphoma 3 Hematopoietic and Lymphatic System Neoplasm 3 Triple Negative Breast Neoplasms 2 Skin Carcinoma 2 Papillomavirus Infections 2 Hematologic Neoplasms 2 Anatomic Stage I Breast Cancer AJCC v8 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Testicular Neoplasms 1 Substance-Related Disorders 1 Sarcoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Ovarian Neoplasms 1 Opioid-Related Disorders 1 Neoplasms 1 Lymphoma, Follicular 1 Leukemia, Myeloid, Acute 1 Inflammatory Breast Neoplasms 1 Glioblastoma 1 Genital Neoplasms, Female 1 Gastrointestinal Neoplasms 1

Interventions

pembrolizumab 55 Cisplatin 35 Cetuximab 26 Carboplatin 24 Radiotherapy 18 Radiotherapy, Intensity-Modulated 17 Magnetic Resonance Spectroscopy 16 Specimen Handling 14 Paclitaxel 14 Nivolumab 14 Docetaxel 14 Platinum 8 Fluorouracil 8 1,2-diaminocyclohexaneplatinum II citrate 8 Biopsy 6 (225)Ac-DOTA-c(RGDyK) 6 atezolizumab 5 Radiation 5 Ipilimumab 5 Drug Therapy 5 durvalumab 4 cemiplimab 4 Taxes 4 Standard of Care 4 Radiosurgery 4 Immunoglobulin G 4 Immune Checkpoint Inhibitors 4 Cyclophosphamide 4 Chemoradiotherapy 4 toripalimab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡